Study of Smoking Trajectory in Newly Diagnosis Lung Cancer Patients

August 20, 2018 updated by: Yang Chia Chen, National Defense Medical Center, Taiwan

Smoking Trajectory in Newly Diagnosis Lung Cancer Patients

  1. Understanding the smoking change patterns among the newly diagnosis lung cancer patients after cancer diagnosis.
  2. Explore the related factors of the smoking change patterns.
  3. The type of smoking trajectory impact on survival and quality of life.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This was a prospective longitudinal design study. The investigators used the structure questionnaires to collect the data from a consecutive sample of newly diagnosed lung cancer patients.

Study Type

Observational

Enrollment (Actual)

406

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Newly diagnosed lung cancer patients

Description

Inclusion Criteria:

  • Over 20 years old
  • Newly diagnosed lung cancer
  • Conscious clear and able to communicate
  • Agreed to participate the study

Exclusion Criteria:

  • Consciously confused
  • Cognitive or psychotic disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes From Baseline Smoking Behavior at 1,2,3,4,5,6 Months
Time Frame: baseline, 1-month, 2-month, 3-month, 4-month, 5-month, 6-month
Self-reported smoking during the last 30 days was a dichotomous variable.
baseline, 1-month, 2-month, 3-month, 4-month, 5-month, 6-month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes From Baseline Quality of Life at 1,2,3,4,5,6 Months
Time Frame: baseline, 1-month, 2-month, 3-month, 4-month, 5-month, 6-month
Functional Assessment of Cancer Therapy-Lung, Version 4 (FACT-L v. 4) was a 36-item ordinal scale, five-point scale from 0 (not at all) to 4 (very much). There were 5 domains: Physical, social/family, emotional, and functional well-being; lung cancer subscale (symptoms, cognitive function, regret of smoking). Subscale scores added to obtain total score, with higher scores indicating better quality of life.
baseline, 1-month, 2-month, 3-month, 4-month, 5-month, 6-month
Proportion of participants with Overall Survival up to 2 years
Time Frame: follow up to one or two years
survival
follow up to one or two years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Defense Medical Center, Taiwan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 24, 2014

Primary Completion (Actual)

July 22, 2017

Study Completion (Actual)

July 30, 2018

Study Registration Dates

First Submitted

August 14, 2018

First Submitted That Met QC Criteria

August 20, 2018

First Posted (Actual)

August 22, 2018

Study Record Updates

Last Update Posted (Actual)

August 22, 2018

Last Update Submitted That Met QC Criteria

August 20, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TWNA-1042011

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on smoking

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe